Mosaic ImmunoEngineering Inc.

0.8380+0.33 (+64.3%)

Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · CPMV · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

6.07M

P/E (TTM)

Basic EPS (TTM)

-0.10

Dividend Yield

Recent Filings

10-Q

8/19/25Aug 19, 2025

10-Q

5/20/25May 20, 2025

10-K

4/15/25Apr 15, 2025

8-K

1/2/25Jan 2, 2025

10-Q

11/19/24Nov 19, 2024

About

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.

CEO

Mr. Steven W. King

IPO

1/2/2013

Website

https://www.mosaicie.com

Employees

Sector

Healthcare

Industry

Biotechnology